Each film coated tablet contains Empagliflozin INN 5 mg & Metformin Hydrochloride USP 500 mg.
Emparol-M is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes when treatment with bothempagliflozin and metformin is appropriate. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.
Each film coated tablet contains Empagliflozin INN 5 mg & Metformin Hydrochloride USP 500 mg.
Emparol-M is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes when treatment with bothempagliflozin and metformin is appropriate. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.